Reports 4Q revenue $134.8M vs, $116.8M last year..Reports Q4 home closings of 414, an increase of 7% year over year compared to 387 home ...

Vertex Pharmaceuticals’ (VRTX) non-opioid pain drug Journavx was picked up by UnitedHealth’s (UNH) Optum on “Tier 3.” The insurer said, ...

Trump’s allegiance to Oz was further emphasized on Tuesday when the president announced he was nominating Oz’s son-in-law, ...

U.S. drugmakers Johnson & Johnson and Eli Lilly increased spending on security for their top executives in 2024, citing ...

SentinelOne forecast its first-quarter and annual revenue below Wall Street estimates on Wednesday, hurt by tough competition and softer enterprise spending due to economic uncertainty, sending its ...

The lawsuit alleges that the UnitedHealth Group subsidiary’s cybersecurity standards were insufficient to prevent the attack.

CHAPIN, S.C., February 24, 2025--United Homes Group (NASDAQ: UHG) announced today that the company will release its results for the fourth quarter of 2024 before the market opens on Wednesday ...

In one of our recent articles, titled 11 Best Undervalued Stocks to Invest in Now, we talked about how the recent tariffs have caused a slowdown in the market and are likely to cause inflation ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists.

Comedian Andrew Schulz told podcast host Joe Rogan in an interview posted Thursday that Democrats will continue to lose elections if they do not stop talking “down” […] ...